http://orcid.org/0000-0002-5795-5241
REFERENCES
- Aymé, S., A. Kole, and S. Groft. 2008. Empowerment of patients: Lessons from the rare diseases community. The Lancet 371(9629): 2048–2051.
- Cridland, E. K., S. C. Jones, C. A. Magee, and P. Caputi. 2014. Family-focused autism spectrum disorder research: A review of the utility of family systems approaches. Autism 18(3): 213–222.
- Eckstrand, K. L., J. Eliason, J. Potter, and T. St Cloud. 2016. The priority of intersectionality in academic medicine. Academic Medicine 91(7): 904–907. doi: 10.1097/acm.0000000000001231
- Gibbon, S., and C. Novas. 2007. Biosocialities, genetics and the social sciences. New York: Routledge.
- Jutel, A., and S. Nettleton. 2011. Towards a sociology of diagnosis: Reflections and opportunities. Social Science and Medicine (1982). 73(6): 793–800.
- Koay, P. P., and R. R. Sharp. 2013. The role of patient advocacy organizations in shaping genomic science. Annual Review of Genomics and Human Genetics 14(1): 579–595.
- Lai, M.-C., M. V. Lombardo, B. Chakrabarti, and S. Baron-Cohen. 2013. Subgrouping the autism “spectrum”: Reflections on DSM-5. PLOS Biology 11(4): e1001544.
- McCoy, M., E.Y. Liu, A.S.F. Lutz, and D. Sisti, et al. 2020. Ethical Advocacy Across the Autism Spectrum: Beyond Partial Representation. American Journal of Bioethics 20(4): 13–24.
- Rabinow, P. 2010. Artificiality and enlightenment: From sociobiology to biosociality. Politix 90(2): 21–46.
- Volkmar, F., M. Siegel, M. Woodbury-Smith, B. King, J. McCracken, and M. State. 2014. Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder. Journal of the American Academy of Child and Adolescent Psychiatry 53(2): 237–257.